Aminothiols in human brain tumors

Marie Bicíková1, Lubomír Kríz, Milan Mohapl

  • 1Institute of Endocrinology, Prague, Czech Republic. mbicikova@endo.cz

Abstract

Insights

This study found elevated homocysteine (an aminothiol) in human brain tumors, particularly pituitary adenoma and glioblastoma. These findings suggest homocysteine

Area of Science:

  • Biochemistry
  • Neuroscience
  • Oncology

Background:

  • Aminothiols, sulfur-containing amino acids, are crucial in methionine metabolism.
  • Altered aminothiol levels are implicated in various diseases, potentially through direct toxicity or interference with transmethylation.
  • Elevated homocysteine in brain tissue may contribute to oxidative stress and excitotoxicity.

Purpose of the Study:

  • To investigate the concentrations of key aminothiols in human brain tumor tissues.
  • To explore the role of aminothiols in the context of brain tumor development and progression.

Main Methods:

  • Analysis of cytosolic fractions from 73 human brain tumor samples.
  • Quantification of total homocysteine, total cysteine, and methionine using gas chromatography with flame ionization detection.

Main Results:

  • Average concentrations: total homocysteine (0.58-1.51 nmol/mg), methionine (1.16-2.07 nmol/mg), and total cysteine (5.08-7.82 nmol/mg).
  • Significantly higher total homocysteine levels were observed in pituitary adenoma and glioblastoma multiforme.
  • Methionine and cysteine concentrations did not show significant variations across different tumor types.

Conclusions:

  • This is the first study to report aminothiol concentrations in human brain tumors.
  • The findings highlight the involvement of specific metabolic pathways in tumor formation and progression.
  • The results underscore the potential toxic effects of homocysteine in the context of brain neoplasms.

Related Concept Videos